Concepedia

Antoine Huart

AH

Statistics

Publications

37

Citations

2.7K

H-Index

23

Active since

2012

Affiliations

Inserm(Current)

Université Toulouse III - Paul Sabatier

Hôpital Rangueil

Centre Hospitalier Universitaire de Toulouse

Assistance Publique – Hôpitaux de Paris

Antoine Huart is an author at Inserm specializing in medicine, immunology, and immunopathology.

ORCID

Publications per year

2012–2024

37

Publications

37

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

, , +15

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 336 citations

, , +15

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

Benjamin Terrier, Evguenia Krastinova, I. Marie et al. · Blood · 2012 · 240 citations · Full text

, , +10

Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Pierre Charles, Élodie Perrodeau, M. Samson et al. · Annals of Internal Medicine · 2020 · 193 citations

, , +17

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Murielle Roussel, Giampaolo Merlini, Sylvie Chevret et al. · Blood · 2020 · 126 citations · Full text

, , +12

1–5 of 37